Dette randomiserede forsøg med patienter med metastatisk colorectal cancer, som ikke tidligere havde fået behandling for metastatisk sygdom, sammenlignede kombinationen af cetuximab og oxaliplatin plus 5- fluorouracil / folinsyre- infusion (5- FU/ FA) (169 patienter) med den samme kemoterapibehandling uden cetuximab (168 patienter).
This randomised study in patients with metastatic colorectal cancer who had not received prior treatment for metastatic disease compared the combination of cetuximab and oxaliplatin plus infusional 5-fluorouracil/ folinic acid (5-FU/ FA) (169 patients) to the same chemotherapy alone (168 patients).